We write to express our deep gratitude for your leadership in authoring S. 3427, the
Neuroscience Center of Excellence Act, which would require the establishment of a
Neuroscience Center of Excellence (NCOE) at the Food and Drug Administration (FDA).
We are also writing to request that you support the inclusion of $3 million in funding and
accompanying report language for the Neurology Drug Program at the FDA in the Senate
Appropriations Committee’s draft fiscal year (FY) 23 Agriculture, Rural Development, FDA, and
Related Agencies Appropriations bill. This investment would be critical to help improve FDA’s
capacity and capability to further neuroscience guidance and accelerate innovation.